StockWatch
·

Sudarshan Pharma Industries Ltd Q1 FY26 Results

SUDARSHANQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue145.2647.6%
Total Income146.4747.4%
Expenditure141.0646.4%
PBT5.4160.2%
Net Profit3.9660.3%
OPM7.60%6.53pp
NPM2.70%0.88pp
EPS0.1661.0%
View full financials

Informational and educational content only. Not investment advice.